Early prevention progress of contrast induced nephropathy
10.3760/cma.j.issn.2095-4352.2019.09.025
- VernacularTitle: 造影剂肾病早期预防的研究进展
- Author:
Wentao SANG
1
,
2
;
Kehui YANG
1
,
2
;
Xiao LI
3
;
Feng XU
3
;
Jian ZHANG
1
,
2
;
Hongzhi WU
1
,
2
;
Tangxing JIANG
1
,
2
;
Yuguo CHEN
3
Author Information
1. School of Medicine, Shandong University, Jinan 250012, Shandong, China
2. Department of Emergency Medicine and Chest Pain Center, Qilu Hospital of Shandong University, Institute of Emergency and Critical Care Medicine of Shandong University, Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Shandong Emergency and Critical Care Clinical Medical Research Center, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Key Laboratory of Cardiovascular Remodeling & Function Research, Chinese Ministry of Education & Chinese Ministry of Public Health, Jinan 250012, Shandong, China
3. Department of Emergency Medicine and Chest Pain Center, Qilu Hospital of Shandong University, Institute of Emergency and Critical Care Medicine of Shandong University, Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Shandong Emergency and Critical Care Clinical Medical Research Center, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Key Laboratory of Cardiovascular Remodeling & Function Research, Chinese Ministry of Education & Chinese Ministry of Public Health, Jinan 250012, Shandong, China
- Publication Type:Review
- Keywords:
Contrast induced nephropathy;
Prevention;
Hydration;
Statin
- From:
Chinese Critical Care Medicine
2019;31(9):1174-1178
- CountryChina
- Language:Chinese
-
Abstract:
Contrast induced nephropathy (CIN) is acute renal injury following administration of contrast media during angiographic or other medical procedures, which represents as the third cause of hospital-acquired renal failure. CIN is associated with prolonged hospital stay, increased health-care costs, and undesirable clinical outcome. The risk of CIN includes advanced age and diabetes mellitus. With the rapid development of iconography and the wide application of interventional techniques, the patients with CIN are increasing. The preventive measures of CIN include hydration, using appropriate contrast media, stopping nephrotoxic drugs, ischemic preconditioning, renal replacement therapy, and using appropriate drugs. In this paper, the current status and early prevention progress of CIN will be reviewed from three aspects of the high-risk factors, pathogenesis and prevention, aiming to provide guidance for the early prevention of CIN and explore new research directions.
